Preferred Label : calcifediol;
MeSH definition : The major circulating metabolite of VITAMIN D3. It is produced in the LIVER and is
the best indicator of the body's vitamin D stores. It is effective in the treatment
of RICKETS and OSTEOMALACIA, both in azotemic and non-azotemic patients. Calcifediol
also has mineralizing properties.;
MeSH synonym : 25-hydroxyvitamin d3; 25 hydroxycholecalciferol; 25-hydroxycholecalciferol; 25-hydroxyvitamin d 3; 25 hydroxyvitamin d 3; 25 hydroxyvitamin d3; calcidiol; 25-Hydroxycholecalciferol monohydrate; 25 hydroxycholecalciferol monohydrate; monohydrate, 25-Hydroxycholecalciferol;
CISMeF synonym : faes brand of calcifediol; calcifediol faes brand; organon brand of calcifediol; calcifediol organon brand; aventis brand of calcifediol; calcifediol aventis brand;
MeSH hyponym : calcifediol, (3 alpha,5Z,7E)-Isomer; calcifediol, (3 beta,5E,7E)-Isomer; calderol; dedrogyl; calcifediol anhydrous; hidroferol; Anhydrous, Calcifediol;
MeSH CAS label : 9,10-Secocholesta-5,7,10(19)-triene-3,25-diol, (3beta,5Z,7E)-;
MeSH Related Number : calcifediol, (3 alpha,5Z,7E)-Isomer; calcifediol, (3 beta,5E,7E)-Isomer; 19356-17-3 (Calcifediol); 36149-00-5 ((3 beta,5E,7E)-isomer); 73809-05-9 ((3 alpha,5Z,7E)-isomer); calcifediol anhydrous; T0WXW8F54E;
Registry Number MeSH : 19356-17-3;
Related CAS MeSH : 73809-05-9 (Calcifediol, (3 alpha,5Z,7E)-Isomer); 36149-00-5 (Calcifediol, (3 beta,5E,7E)-Isomer); T0WXW8F54E (Calcifediol anhydrous);
MeSH annotation : deficiency: coordinate CALCIFEDIOL /defic (IM) with VITAMIN D DEFICIENCY (IM);
Wikipedia link : https://en.wikipedia.org/wiki/Calcifediol;
Codes EINECS : 242-990-9;
Is substance : O;
UNII : P6YZ13C99Q;
InChIKey : WRLFSJXJGJBFJQ-WPUCQFJDSA-N;
Origin ID : D002112;
UMLS CUI : C0006657;
ATC code(s)
Allowable qualifiers
CISMeF manual mappings
Currated CISMeF NLP mapping
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
The major circulating metabolite of VITAMIN D3. It is produced in the LIVER and is
the best indicator of the body's vitamin D stores. It is effective in the treatment
of RICKETS and OSTEOMALACIA, both in azotemic and non-azotemic patients. Calcifediol
also has mineralizing properties.
https://www.has-sante.fr/jcms/p_3424048/fr/luzadel-calcifediol-deficit-en-vitamine-d
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
Product containing only calcifediol in oral dose form (medicinal product form)
calcifediol
evaluation of the transparency committee
vitamin d deficiency
calcifediol
---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00409
2019
false
false
false
Canada
French
drug information
drug approval
canada
administration, oral
calcifediol
calcifediol
calcifediol
treatment outcome
hyperparathyroidism, secondary
kidney diseases
secondary hyperparathyroidism of renal origin
vitamins
vitamins
adult
---
http://www.has-sante.fr/portail/jcms/c_663657/dedrogyl
http://www.has-sante.fr/portail/jcms/c_1598711/fr/dedrogyl
2013
France
French
corticosteroid therapy
calcifediol
vitamins
administration, oral
calcifediol
insurance, health, reimbursement
infant
adult
child
vitamin d deficiency
vitamin d deficiency
osteomalacia
calcium metabolism disorders
calcium metabolism disorders
renal insufficiency
rickets
evaluation of the transparency committee
---